Review



jvm 2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC jvm 2
    Jvm 2, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 131 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jvm+2/JVM-2/us12600760-911-9-29
    Average 95 stars, based on 131 article reviews
    jvm 2 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors.
    Article Snippet: Various human cell lines were selected as representatives of the different cell types targeted by the 11th HLDA workshop: HDLM-2 (Hodgkin lymphoma), THP-1 (Monocytic leukemia), Jurkat (T cell leukemia), Raji (Burkitt lymphoma), MOLT4 (T cell leukemia), U266 (Multiple myeloma), RPMI8226 (Multiple myeloma), JVM-2 (Chronic B cell leukemia), U937 (Histiocytic lymphoma) (American Tissue Culture Collection [ATCC], Rockville, MD, USA).

    Article Title: Combinations and uses thereof
    Article Snippet: NKs: RPMI1640, with GlutaMAXTM, Invitrogen, Cat No.: 31870-074, 10% FCS; Biocoll: Biochrome AG CAT No.: L6115 LOT No.: 0034D; MACS NK cell isolation kit: Miltenyi Biotec CAT No.: 130-092-657 LOT No.: 5150327376; Idelalisib: Selleck Chem CAT No.: S2226; FCS: Sigma CAT No.: F7524 LOT No.: 111M3396; and RefmAb33 (anti-RSV) with same Fc region as MOR00208.

    Article Title: Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors
    Article Snippet: Cell line BV-173 was purchased from DSMZ.

    Article Title: Combinations and uses thereof
    Article Snippet: JVM-2 (ATCC® CRL-3002) is a mantle cell lymphoma cell line.

    Article Title: CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein‐Coupled Receptors
    Article Snippet: Various human cell lines were selected as representatives of the different cell types targeted by the 11th HLDA workshop: HDLM‐2 (Hodgkin lymphoma), THP‐1 (Monocytic leukemia), Jurkat (T cell leukemia), Raji (Burkitt lymphoma), MOLT4 (T cell leukemia), U266 (Multiple myeloma), RPMI8226 (Multiple myeloma), JVM‐2 (Chronic B cell leukemia), U937 (Histiocytic lymphoma) (American Tissue Culture Collection [ATCC], Rockville, MD, USA).

    Cell Culture:

    Article Title: Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma
    Article Snippet: RPE cells (ATCC; CRL-4000) were cultured in DMEM/F-12 (Gibco). .. Jeko (ATCC; CRL-3006), Mino (ATCC; CRL-3000), JVM-2 (ATCC; CRL-3002), Rec1 (ATCC; CRL-3004), and MCIR cells ( ) were cultured in RPMI-1640 medium (Gibco). .. Z138 cells (ATCC; CRL-3001) were cultured in IMDM (Gibco).

    Article Title: Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma
    Article Snippet: RPE cells (ATCC, CRL-4000) were cultured in DMEM/F-12 (Gibco). .. Jeko (ATCC, CRL-3006), Mino (ATCC, CRL-3000), JVM-2 (ATCC, CRL-3002), Rec1 (ATCC, CRL-3004), and MCIR cells (68) were cultured in Roswell Park Memorial Institute-1640 (RPMI-1640) medium (Gibco). .. Z138 cells (ATCC, CRL-3001) were cultured in Iscove’s Modified Dulbecco’s Medium (IMDM, Gibco).

    Article Title: Chimeric antigen receptors targeting CD79B and CD19
    Article Snippet: .. Cell Lines and Culture The human cell lines Jeko-1, JVM-2 and Granta-519 (MCL), SuDHL-4 and SuDHL-6 (DLBCL), Raji and Daudi (Burkitt's lymphoma), and MM.1s (Multiple Myeloma) were obtained from American Type Culture Collection (ATCC) and cultured in accordance with the supplier's recommendations. .. Parental K562 were purchased from ATCC and modified to express CD19 (K562−CD19+), CD79b (K562− CD79b+), or CD19 and CD79b (K562−CD19+CD79b+).



    Similar Products

    jvm 2  (ATCC)
    95
    ATCC jvm 2
    Jvm 2, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jvm+2/JVM-2/us12600760-911-9-29
    Average 95 stars, based on 1 article reviews
    jvm 2 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    ATCC jvm 2 cll cells
    Jvm 2 Cll Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jvm+2/JVM-2/10__3390_slash_cancers18071078-47-13-20
    Average 95 stars, based on 1 article reviews
    jvm 2 cll cells - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    94
    DSMZ cell line lymphoma type source jvm 2 mcl dsmz
    Cell Line Lymphoma Type Source Jvm 2 Mcl Dsmz, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jvm+2/JVM-2/us12577316-806-0-7
    Average 94 stars, based on 1 article reviews
    cell line lymphoma type source jvm 2 mcl dsmz - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    jvm 2  (DSMZ)
    94
    DSMZ jvm 2
    a , Box-and-whisker plots depicting higher expression (left) and essentiality (right) of EBF1 in Non-Hodgkin B lymphomas compared to T cell leukaemia/lymphoma from DepMap. The number of cell lines are indicated in parentheses. Box-and-whisker plots: centre line, median; box limits, upper (75th) and lower (25th) percentiles; whiskers, 1.5 interquartile range. b , Western blotting of EBF1 in Cas9-expressing <t>JVM-2,</t> Granta519 and PGA-1 MCL showing efficient depletion of EBF1 three days after transfection of sgRNA targeting EBF1. β-actin is loading control. c , d , Flow cytometry plots ( c ) and quantification ( d ) of cell apoptosis and death measured by Annexin V and ToPro-3 staining. Ctrl and EBF1-KO Cas9-expressing MCL cells were sorted three days post lentiviral transduction and cultured for three days. See Supplementary Fig. 1 for gating strategy. Data represent mean ± S.D. of 3 replicates per condition. P value: two-sided t-test. e , Cumulative distribution plot (CDF) of distances between each reproducible EBF1 peak to the closest expressed gene TSS in Granta519 showing > 75% EBF1 peaks are located 10 kb away from TSS. f , Schematics of knocking in FKBP F36V domain at the stop codon of endogenous EBF1 gene in Granta519-Cas9 cells. Single cell clones were selected with blasticidin and successful insertion of the FKBP F36V cassette was validated with genomic DNA PCR. Clones with efficient EBF1 degradation after dTAG V -1 treatment (referred to as dTAG) are used. g , Hierarchical clustering of normalized reads (RPKM) from Ctrl and EBF1-KO Granta519-Cas9, and EBF1-FKBP-KI clones 26, 27, 29, 97 with 0, 6, 24-h 125 nM dTAG treatment showing higher similarity of clones 27 and 97 with Granta519-Cas9 transcriptome. h , Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery rate (FDR) (y axis) in Granta519-EBF1-FKBP-KI clone 27 treated with 125 nM dTAG for 6, 24, 48, 72 h compared with untreated cells. Each point depicts an accessible element, colour coded by blue, red, and black based on significantly decreased, increased, or unchanged accessibility in treated cells, respectively. Significance cutoff: FDR < 1E-5 and Log2(fold change) => 1. i , Heatmaps displaying overall unchanged normalized accessibility levels at dynamic EBF1-binding sites. Each column of ATAC-seq signals is centred on bona fide EBF1-bound elements per Fig. 1d ± 2 Kb flanking sequences with 50 bp resolution. j , Scatterplot of PC1 values of Hi-C contact matrices in Ctrl and EBF1-KO Granta519-Cas9 cells showing largely invariable A/B compartments. k , Box-and-whisker plots of EBF1 (left), YY1 (middle) and H3K27ac (right) loading at the promoters (P) and enhancers (E) interacting with significant long-range DNA loops of SMC1 HiChIP in Granta519. EBF1 preferentially binds enhancers, while YY1 preferentially binds promoters. H3K27ac is negative control. EE: n = 11,818; PE: n = 10,739; PP: n = 3,806. Box-and-whisker plots: see panel a . FWER-adjusted p values: two-side Wilcoxon rank-sum test. l , Venn diagram comparing overlapping of the genomic coordinates of enhancer–promoter hubs in Granta519 SMC1 and EBF1 (RG and MP) HiChIP showing high concordance of hubs identified by three assays. m , Cumulative distribution plots showing expressed genes count in each enhancer–promoter hub defined by EBF1 (RG and MP) and SMC1 HiChIP. n , Box-and-whisker plots showing higher number of genes per megabase in gene-dense compared to gene-sparse hubs defined by EBF1 HiChIP using RG (left) and MP (right) antibodies. The number of hubs in each group is listed in parentheses. Box-and-whisker plots: see panel a . P values: two-sided Wilcoxon rank-sum test. Source numerical data and unprocessed blots are available in Source data .
    Jvm 2, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jvm+2/JVM-2/pmc12818770-621-1-8
    Average 94 stars, based on 1 article reviews
    jvm 2 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    95
    ATCC jvm 2 cell line
    a , Box-and-whisker plots depicting higher expression (left) and essentiality (right) of EBF1 in Non-Hodgkin B lymphomas compared to T cell leukaemia/lymphoma from DepMap. The number of cell lines are indicated in parentheses. Box-and-whisker plots: centre line, median; box limits, upper (75th) and lower (25th) percentiles; whiskers, 1.5 interquartile range. b , Western blotting of EBF1 in Cas9-expressing <t>JVM-2,</t> Granta519 and PGA-1 MCL showing efficient depletion of EBF1 three days after transfection of sgRNA targeting EBF1. β-actin is loading control. c , d , Flow cytometry plots ( c ) and quantification ( d ) of cell apoptosis and death measured by Annexin V and ToPro-3 staining. Ctrl and EBF1-KO Cas9-expressing MCL cells were sorted three days post lentiviral transduction and cultured for three days. See Supplementary Fig. 1 for gating strategy. Data represent mean ± S.D. of 3 replicates per condition. P value: two-sided t-test. e , Cumulative distribution plot (CDF) of distances between each reproducible EBF1 peak to the closest expressed gene TSS in Granta519 showing > 75% EBF1 peaks are located 10 kb away from TSS. f , Schematics of knocking in FKBP F36V domain at the stop codon of endogenous EBF1 gene in Granta519-Cas9 cells. Single cell clones were selected with blasticidin and successful insertion of the FKBP F36V cassette was validated with genomic DNA PCR. Clones with efficient EBF1 degradation after dTAG V -1 treatment (referred to as dTAG) are used. g , Hierarchical clustering of normalized reads (RPKM) from Ctrl and EBF1-KO Granta519-Cas9, and EBF1-FKBP-KI clones 26, 27, 29, 97 with 0, 6, 24-h 125 nM dTAG treatment showing higher similarity of clones 27 and 97 with Granta519-Cas9 transcriptome. h , Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery rate (FDR) (y axis) in Granta519-EBF1-FKBP-KI clone 27 treated with 125 nM dTAG for 6, 24, 48, 72 h compared with untreated cells. Each point depicts an accessible element, colour coded by blue, red, and black based on significantly decreased, increased, or unchanged accessibility in treated cells, respectively. Significance cutoff: FDR < 1E-5 and Log2(fold change) => 1. i , Heatmaps displaying overall unchanged normalized accessibility levels at dynamic EBF1-binding sites. Each column of ATAC-seq signals is centred on bona fide EBF1-bound elements per Fig. 1d ± 2 Kb flanking sequences with 50 bp resolution. j , Scatterplot of PC1 values of Hi-C contact matrices in Ctrl and EBF1-KO Granta519-Cas9 cells showing largely invariable A/B compartments. k , Box-and-whisker plots of EBF1 (left), YY1 (middle) and H3K27ac (right) loading at the promoters (P) and enhancers (E) interacting with significant long-range DNA loops of SMC1 HiChIP in Granta519. EBF1 preferentially binds enhancers, while YY1 preferentially binds promoters. H3K27ac is negative control. EE: n = 11,818; PE: n = 10,739; PP: n = 3,806. Box-and-whisker plots: see panel a . FWER-adjusted p values: two-side Wilcoxon rank-sum test. l , Venn diagram comparing overlapping of the genomic coordinates of enhancer–promoter hubs in Granta519 SMC1 and EBF1 (RG and MP) HiChIP showing high concordance of hubs identified by three assays. m , Cumulative distribution plots showing expressed genes count in each enhancer–promoter hub defined by EBF1 (RG and MP) and SMC1 HiChIP. n , Box-and-whisker plots showing higher number of genes per megabase in gene-dense compared to gene-sparse hubs defined by EBF1 HiChIP using RG (left) and MP (right) antibodies. The number of hubs in each group is listed in parentheses. Box-and-whisker plots: see panel a . P values: two-sided Wilcoxon rank-sum test. Source numerical data and unprocessed blots are available in Source data .
    Jvm 2 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jvm+2/JVM-2/pmc12744261-29-1-7
    Average 95 stars, based on 1 article reviews
    jvm 2 cell line - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    jvm2  (DSMZ)
    94
    DSMZ jvm2
    a , Box-and-whisker plots depicting higher expression (left) and essentiality (right) of EBF1 in Non-Hodgkin B lymphomas compared to T cell leukaemia/lymphoma from DepMap. The number of cell lines are indicated in parentheses. Box-and-whisker plots: centre line, median; box limits, upper (75th) and lower (25th) percentiles; whiskers, 1.5 interquartile range. b , Western blotting of EBF1 in Cas9-expressing <t>JVM-2,</t> Granta519 and PGA-1 MCL showing efficient depletion of EBF1 three days after transfection of sgRNA targeting EBF1. β-actin is loading control. c , d , Flow cytometry plots ( c ) and quantification ( d ) of cell apoptosis and death measured by Annexin V and ToPro-3 staining. Ctrl and EBF1-KO Cas9-expressing MCL cells were sorted three days post lentiviral transduction and cultured for three days. See Supplementary Fig. 1 for gating strategy. Data represent mean ± S.D. of 3 replicates per condition. P value: two-sided t-test. e , Cumulative distribution plot (CDF) of distances between each reproducible EBF1 peak to the closest expressed gene TSS in Granta519 showing > 75% EBF1 peaks are located 10 kb away from TSS. f , Schematics of knocking in FKBP F36V domain at the stop codon of endogenous EBF1 gene in Granta519-Cas9 cells. Single cell clones were selected with blasticidin and successful insertion of the FKBP F36V cassette was validated with genomic DNA PCR. Clones with efficient EBF1 degradation after dTAG V -1 treatment (referred to as dTAG) are used. g , Hierarchical clustering of normalized reads (RPKM) from Ctrl and EBF1-KO Granta519-Cas9, and EBF1-FKBP-KI clones 26, 27, 29, 97 with 0, 6, 24-h 125 nM dTAG treatment showing higher similarity of clones 27 and 97 with Granta519-Cas9 transcriptome. h , Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery rate (FDR) (y axis) in Granta519-EBF1-FKBP-KI clone 27 treated with 125 nM dTAG for 6, 24, 48, 72 h compared with untreated cells. Each point depicts an accessible element, colour coded by blue, red, and black based on significantly decreased, increased, or unchanged accessibility in treated cells, respectively. Significance cutoff: FDR < 1E-5 and Log2(fold change) => 1. i , Heatmaps displaying overall unchanged normalized accessibility levels at dynamic EBF1-binding sites. Each column of ATAC-seq signals is centred on bona fide EBF1-bound elements per Fig. 1d ± 2 Kb flanking sequences with 50 bp resolution. j , Scatterplot of PC1 values of Hi-C contact matrices in Ctrl and EBF1-KO Granta519-Cas9 cells showing largely invariable A/B compartments. k , Box-and-whisker plots of EBF1 (left), YY1 (middle) and H3K27ac (right) loading at the promoters (P) and enhancers (E) interacting with significant long-range DNA loops of SMC1 HiChIP in Granta519. EBF1 preferentially binds enhancers, while YY1 preferentially binds promoters. H3K27ac is negative control. EE: n = 11,818; PE: n = 10,739; PP: n = 3,806. Box-and-whisker plots: see panel a . FWER-adjusted p values: two-side Wilcoxon rank-sum test. l , Venn diagram comparing overlapping of the genomic coordinates of enhancer–promoter hubs in Granta519 SMC1 and EBF1 (RG and MP) HiChIP showing high concordance of hubs identified by three assays. m , Cumulative distribution plots showing expressed genes count in each enhancer–promoter hub defined by EBF1 (RG and MP) and SMC1 HiChIP. n , Box-and-whisker plots showing higher number of genes per megabase in gene-dense compared to gene-sparse hubs defined by EBF1 HiChIP using RG (left) and MP (right) antibodies. The number of hubs in each group is listed in parentheses. Box-and-whisker plots: see panel a . P values: two-sided Wilcoxon rank-sum test. Source numerical data and unprocessed blots are available in Source data .
    Jvm2, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jvm+2/JVM-2/pm41167303-84-31-45
    Average 94 stars, based on 1 article reviews
    jvm2 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    a , Box-and-whisker plots depicting higher expression (left) and essentiality (right) of EBF1 in Non-Hodgkin B lymphomas compared to T cell leukaemia/lymphoma from DepMap. The number of cell lines are indicated in parentheses. Box-and-whisker plots: centre line, median; box limits, upper (75th) and lower (25th) percentiles; whiskers, 1.5 interquartile range. b , Western blotting of EBF1 in Cas9-expressing JVM-2, Granta519 and PGA-1 MCL showing efficient depletion of EBF1 three days after transfection of sgRNA targeting EBF1. β-actin is loading control. c , d , Flow cytometry plots ( c ) and quantification ( d ) of cell apoptosis and death measured by Annexin V and ToPro-3 staining. Ctrl and EBF1-KO Cas9-expressing MCL cells were sorted three days post lentiviral transduction and cultured for three days. See Supplementary Fig. 1 for gating strategy. Data represent mean ± S.D. of 3 replicates per condition. P value: two-sided t-test. e , Cumulative distribution plot (CDF) of distances between each reproducible EBF1 peak to the closest expressed gene TSS in Granta519 showing > 75% EBF1 peaks are located 10 kb away from TSS. f , Schematics of knocking in FKBP F36V domain at the stop codon of endogenous EBF1 gene in Granta519-Cas9 cells. Single cell clones were selected with blasticidin and successful insertion of the FKBP F36V cassette was validated with genomic DNA PCR. Clones with efficient EBF1 degradation after dTAG V -1 treatment (referred to as dTAG) are used. g , Hierarchical clustering of normalized reads (RPKM) from Ctrl and EBF1-KO Granta519-Cas9, and EBF1-FKBP-KI clones 26, 27, 29, 97 with 0, 6, 24-h 125 nM dTAG treatment showing higher similarity of clones 27 and 97 with Granta519-Cas9 transcriptome. h , Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery rate (FDR) (y axis) in Granta519-EBF1-FKBP-KI clone 27 treated with 125 nM dTAG for 6, 24, 48, 72 h compared with untreated cells. Each point depicts an accessible element, colour coded by blue, red, and black based on significantly decreased, increased, or unchanged accessibility in treated cells, respectively. Significance cutoff: FDR < 1E-5 and Log2(fold change) => 1. i , Heatmaps displaying overall unchanged normalized accessibility levels at dynamic EBF1-binding sites. Each column of ATAC-seq signals is centred on bona fide EBF1-bound elements per Fig. 1d ± 2 Kb flanking sequences with 50 bp resolution. j , Scatterplot of PC1 values of Hi-C contact matrices in Ctrl and EBF1-KO Granta519-Cas9 cells showing largely invariable A/B compartments. k , Box-and-whisker plots of EBF1 (left), YY1 (middle) and H3K27ac (right) loading at the promoters (P) and enhancers (E) interacting with significant long-range DNA loops of SMC1 HiChIP in Granta519. EBF1 preferentially binds enhancers, while YY1 preferentially binds promoters. H3K27ac is negative control. EE: n = 11,818; PE: n = 10,739; PP: n = 3,806. Box-and-whisker plots: see panel a . FWER-adjusted p values: two-side Wilcoxon rank-sum test. l , Venn diagram comparing overlapping of the genomic coordinates of enhancer–promoter hubs in Granta519 SMC1 and EBF1 (RG and MP) HiChIP showing high concordance of hubs identified by three assays. m , Cumulative distribution plots showing expressed genes count in each enhancer–promoter hub defined by EBF1 (RG and MP) and SMC1 HiChIP. n , Box-and-whisker plots showing higher number of genes per megabase in gene-dense compared to gene-sparse hubs defined by EBF1 HiChIP using RG (left) and MP (right) antibodies. The number of hubs in each group is listed in parentheses. Box-and-whisker plots: see panel a . P values: two-sided Wilcoxon rank-sum test. Source numerical data and unprocessed blots are available in Source data .

    Journal: Nature cell biology

    Article Title: Lineage-determining transcription factors constrain cohesin to drive multi-enhancer oncogene regulation

    doi: 10.1038/s41556-025-01827-2

    Figure Lengend Snippet: a , Box-and-whisker plots depicting higher expression (left) and essentiality (right) of EBF1 in Non-Hodgkin B lymphomas compared to T cell leukaemia/lymphoma from DepMap. The number of cell lines are indicated in parentheses. Box-and-whisker plots: centre line, median; box limits, upper (75th) and lower (25th) percentiles; whiskers, 1.5 interquartile range. b , Western blotting of EBF1 in Cas9-expressing JVM-2, Granta519 and PGA-1 MCL showing efficient depletion of EBF1 three days after transfection of sgRNA targeting EBF1. β-actin is loading control. c , d , Flow cytometry plots ( c ) and quantification ( d ) of cell apoptosis and death measured by Annexin V and ToPro-3 staining. Ctrl and EBF1-KO Cas9-expressing MCL cells were sorted three days post lentiviral transduction and cultured for three days. See Supplementary Fig. 1 for gating strategy. Data represent mean ± S.D. of 3 replicates per condition. P value: two-sided t-test. e , Cumulative distribution plot (CDF) of distances between each reproducible EBF1 peak to the closest expressed gene TSS in Granta519 showing > 75% EBF1 peaks are located 10 kb away from TSS. f , Schematics of knocking in FKBP F36V domain at the stop codon of endogenous EBF1 gene in Granta519-Cas9 cells. Single cell clones were selected with blasticidin and successful insertion of the FKBP F36V cassette was validated with genomic DNA PCR. Clones with efficient EBF1 degradation after dTAG V -1 treatment (referred to as dTAG) are used. g , Hierarchical clustering of normalized reads (RPKM) from Ctrl and EBF1-KO Granta519-Cas9, and EBF1-FKBP-KI clones 26, 27, 29, 97 with 0, 6, 24-h 125 nM dTAG treatment showing higher similarity of clones 27 and 97 with Granta519-Cas9 transcriptome. h , Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery rate (FDR) (y axis) in Granta519-EBF1-FKBP-KI clone 27 treated with 125 nM dTAG for 6, 24, 48, 72 h compared with untreated cells. Each point depicts an accessible element, colour coded by blue, red, and black based on significantly decreased, increased, or unchanged accessibility in treated cells, respectively. Significance cutoff: FDR < 1E-5 and Log2(fold change) => 1. i , Heatmaps displaying overall unchanged normalized accessibility levels at dynamic EBF1-binding sites. Each column of ATAC-seq signals is centred on bona fide EBF1-bound elements per Fig. 1d ± 2 Kb flanking sequences with 50 bp resolution. j , Scatterplot of PC1 values of Hi-C contact matrices in Ctrl and EBF1-KO Granta519-Cas9 cells showing largely invariable A/B compartments. k , Box-and-whisker plots of EBF1 (left), YY1 (middle) and H3K27ac (right) loading at the promoters (P) and enhancers (E) interacting with significant long-range DNA loops of SMC1 HiChIP in Granta519. EBF1 preferentially binds enhancers, while YY1 preferentially binds promoters. H3K27ac is negative control. EE: n = 11,818; PE: n = 10,739; PP: n = 3,806. Box-and-whisker plots: see panel a . FWER-adjusted p values: two-side Wilcoxon rank-sum test. l , Venn diagram comparing overlapping of the genomic coordinates of enhancer–promoter hubs in Granta519 SMC1 and EBF1 (RG and MP) HiChIP showing high concordance of hubs identified by three assays. m , Cumulative distribution plots showing expressed genes count in each enhancer–promoter hub defined by EBF1 (RG and MP) and SMC1 HiChIP. n , Box-and-whisker plots showing higher number of genes per megabase in gene-dense compared to gene-sparse hubs defined by EBF1 HiChIP using RG (left) and MP (right) antibodies. The number of hubs in each group is listed in parentheses. Box-and-whisker plots: see panel a . P values: two-sided Wilcoxon rank-sum test. Source numerical data and unprocessed blots are available in Source data .

    Article Snippet: DND41, JVM-2 and PGA-1 were purchased from the Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Lines (DSMZ, cat. nos.

    Techniques: Whisker Assay, Expressing, Western Blot, Transfection, Control, Flow Cytometry, Staining, Transduction, Cell Culture, Clone Assay, Binding Assay, Hi-C, HiChIP, Negative Control